News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
291,438 Results
Type
Article (15461)
Company Profile (227)
Press Release (275745)
Multimedia
Podcasts (110)
Webinars (12)
Section
Business (90693)
Career Advice (168)
Deals (13479)
Drug Delivery (49)
Drug Development (50962)
Employer Resources (31)
FDA (5965)
Job Trends (5203)
News (145728)
Policy (10100)
Tag
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (1)
2027 Genetown Standard (4)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (956)
Accelerated approval (34)
ADA (33)
Adcomms (16)
Allergies (118)
Alliances (21768)
ALS (178)
Alzheimer's disease (1204)
Antibody-drug conjugate (ADC) (454)
Approvals (6303)
Artificial intelligence (406)
ASCO (221)
Autoimmune disease (303)
Automation (16)
Bankruptcy (108)
Best Places to Work (4560)
BIO (54)
BIOSECURE Act (6)
Biosimilars (140)
BioSpace Insights (71)
Biotechnology (176)
Bladder cancer (128)
Brain cancer (59)
Breast cancer (452)
Cancer (4336)
Cardiovascular disease (323)
Career advice (161)
Career pathing (13)
CAR-T (300)
CDC (8)
Celiac Disease (1)
Cell therapy (789)
Cervical cancer (25)
Clinical research (45552)
Collaboration (1586)
Commercialization (4)
Company closure (3)
Compensation (853)
Complete response letters (68)
COVID-19 (1134)
CRISPR (116)
C-suite (877)
Cystic fibrosis (125)
Data (6300)
Denatured (23)
Depression (126)
Dermatology (73)
Diabetes (356)
Diagnostics (1503)
Digital health (19)
Diversity (6)
Diversity, equity & inclusion (9)
Drug discovery (313)
Drug pricing (54)
Drug shortages (3)
Duchenne muscular dystrophy (311)
Earnings (33340)
Editorial (36)
Employer branding (4)
Employer resources (29)
Events (54038)
Executive appointments (746)
FDA (8403)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (24)
Frontotemporal dementia (32)
Funding (1320)
Gene editing (241)
Generative AI (41)
Gene therapy (646)
GLP-1 (587)
Government (1197)
Grass and pollen (3)
Guidances (179)
Healthcare (6752)
Hematology (118)
HIV (31)
Huntington's disease (61)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (102)
Immunology and inflammation (260)
Immuno-oncology (88)
Indications (152)
Infectious disease (1298)
Inflammatory bowel disease (188)
Inflation Reduction Act (10)
Influenza (61)
Intellectual property (231)
Interviews (20)
IPO (7408)
IRA (13)
Job creations (870)
Job search strategy (135)
JPM (41)
Kidney cancer (11)
Labor market (36)
Layoffs (266)
Leadership (15)
Legal (1405)
Licensing (9)
Liver cancer (48)
Longevity (26)
Lung cancer (577)
Lymphoma (334)
Machine learning (35)
Management (7)
Manufacturing (589)
Marketing (9)
MASH (170)
Medical affairs (1)
Medical device (2731)
Medtech (2767)
Mergers & acquisitions (6880)
Metabolic disorders (984)
mRNA (180)
Multiple sclerosis (133)
NASH (14)
Neurodegenerative disease (375)
Neuropsychiatric disorders (91)
Neuroscience (2511)
Neurotech (1)
NextGen: Class of 2026 (2040)
Non-profit (886)
Now hiring (42)
Obesity (436)
Opinion (146)
Ovarian cancer (199)
Pain (144)
Pancreatic cancer (258)
Parkinson's disease (330)
Partnered (14)
Patents (437)
Patient recruitment (621)
Peanut (51)
People (27515)
Pharmaceutical (29)
Pharmacy benefit managers (6)
Phase 1 (16133)
Phase 2 (21188)
Phase 3 (13375)
Pipeline (7137)
Policy (108)
Postmarket research (853)
Preclinical (6817)
Press Release (30)
Prostate cancer (218)
Psychedelics (74)
Radiopharmaceuticals (301)
Rare diseases (1001)
Real estate (1460)
Recruiting (12)
Regulatory (10946)
Reports (24)
Research institute (997)
Resumes & cover letters (20)
Rett syndrome (42)
RNA editing (31)
RSV (25)
Schizophrenia (155)
Series A (257)
Series B (183)
Service/supplier (1)
Sickle cell disease (98)
Special edition (21)
Spinal muscular atrophy (127)
Sponsored (17)
Startups (2037)
State (1)
Stomach cancer (5)
Supply chain (41)
Tariffs (19)
The Weekly (85)
Vaccines (423)
Venture capital (98)
Weight loss (233)
Women's health (50)
Worklife (2)
Date
Last 7 days (397)
Last 30 days (1391)
Last 365 days (18021)
2026 (11458)
2025 (18110)
2024 (20483)
2023 (22423)
2022 (26823)
2021 (27824)
2020 (23372)
2019 (16230)
2018 (11738)
2017 (13745)
2016 (11840)
2015 (14351)
2014 (10395)
2013 (7486)
2012 (7533)
2011 (7617)
2010 (7429)
Location
Africa (156)
Alabama (79)
Alaska (2)
Arizona (92)
Arkansas (6)
Asia (18904)
Australia (3251)
California (9264)
Canada (2334)
China (1141)
Colorado (330)
Connecticut (345)
Delaware (317)
Europe (40611)
Florida (1209)
Georgia (267)
Hawaii (3)
Idaho (18)
Illinois (563)
India (57)
Indiana (220)
Iowa (9)
Japan (341)
Kansas (89)
Kentucky (11)
Louisiana (17)
Maine (14)
Maryland (944)
Massachusetts (7357)
Michigan (131)
Minnesota (325)
Mississippi (3)
Missouri (38)
Montana (17)
Nebraska (6)
Nevada (51)
New Hampshire (22)
New Jersey (2087)
New Mexico (13)
New York (2285)
North Carolina (1074)
North Dakota (7)
Northern California (4754)
Ohio (230)
Oklahoma (11)
Oregon (25)
Pennsylvania (1685)
Puerto Rico (12)
Rhode Island (26)
South America (216)
South Carolina (13)
Southern California (3729)
Tennessee (62)
Texas (1275)
United States (30515)
Utah (128)
Virginia (185)
Washington D.C. (37)
Washington State (754)
West Virginia (1)
Wisconsin (66)
291,438 Results for "rezo therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Rezo Therapeutics Appoints Nadir Mahmood, Ph.D., as Chief Executive Officer
Rezo Therapeutics today announced the appointment of Nadir Mahmood, Ph.D., as chief executive officer and board member.
September 20, 2023
·
2 min read
Biotech Bay
Rezo Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
Rezo Therapeutics announced today that Nevan Krogan, Ph.D., co-founder and chief executive officer, will present a company overview at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
January 9, 2023
·
1 min read
Biotech Bay
Rezo, Founded by Renowned UCSF Scientists, Launches with $78 Million Series A to Advance Pipeline of Precision Therapeutics Based on Groundbreaking Integrated Disease Network Mapping Platform
Rezo Therapeutics, a biotechnology company pioneering the integrated mapping of disease networks for precision therapeutics, launched with $78 million from a Series A financing.
November 17, 2022
·
4 min read
Press Releases
Akari Therapeutics Enters Strategic Research Collaboration with Whitehawk Therapeutics
July 21, 2026
·
7 min read
Press Releases
Rezon Bio Appoints Dr. Hubert Scholze as Chief Business Officer to Accelerate Global Commercial Expansion
July 1, 2026
·
3 min read
Press Releases
Nektar Therapeutics Announces Second Quarter 2026 Financial Results
August 14, 2026
·
12 min read
Press Releases
United Therapeutics Corporation Acquires Thymmune Therapeutics
July 2, 2026
·
4 min read
Layoffs
ADC Therapeutics lays off staff after 27 patient deaths mar Zynlonta readout
After 27 deaths were reported in a group receiving its blood cancer drug, ADC Therapeutics is downsizing, implementing layoffs for about 30 workers.
June 24, 2026
·
2 min read
·
Gabrielle Masson
Series B
City Therapeutics builds RNAi pipeline with $99.5M series B
City Therapeutics, one of
BioSpace
’s NextGen companies for 2026, was started by RNA royalty John Maraganore, former CEO of Alnylam.
June 8, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Avalo Therapeutics to Participate in the Leerink Partners Therapeutics Forum
July 7, 2026
·
1 min read
1 of 29,144
Next
